Revance Therapeutics Inc (RVNC)
3.005
-0.16
(-4.91%)
USD |
NASDAQ |
May 21, 16:00
3.005
0.00 (0.00%)
After-Hours: 17:15
Revance Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2023 | 37.66 |
| September 28, 2023 | 38.58 |
| September 27, 2023 | 39.70 |
| September 26, 2023 | 40.78 |
| September 25, 2023 | 41.21 |
| September 22, 2023 | 42.72 |
| September 21, 2023 | 40.95 |
| September 20, 2023 | 43.16 |
| September 19, 2023 | 45.35 |
| September 18, 2023 | 54.84 |
| September 15, 2023 | 55.16 |
| September 14, 2023 | 56.64 |
| September 13, 2023 | 55.89 |
| September 12, 2023 | 52.90 |
| September 11, 2023 | 50.67 |
| September 08, 2023 | 50.86 |
| September 07, 2023 | 54.44 |
| September 06, 2023 | 55.53 |
| September 05, 2023 | 57.43 |
| September 01, 2023 | 59.63 |
| August 31, 2023 | 57.89 |
| August 30, 2023 | 58.68 |
| August 29, 2023 | 59.99 |
| August 28, 2023 | 60.06 |
| August 25, 2023 | 60.75 |
| Date | Value |
|---|---|
| August 24, 2023 | 60.94 |
| August 23, 2023 | 61.11 |
| August 22, 2023 | 58.74 |
| August 21, 2023 | 57.63 |
| August 18, 2023 | 56.84 |
| August 17, 2023 | 57.86 |
| August 16, 2023 | 61.58 |
| August 15, 2023 | 61.73 |
| August 14, 2023 | 63.90 |
| August 11, 2023 | 62.09 |
| August 10, 2023 | 64.56 |
| August 09, 2023 | 66.40 |
| August 08, 2023 | 72.21 |
| August 07, 2023 | 71.25 |
| August 04, 2023 | 74.70 |
| August 03, 2023 | 75.52 |
| August 02, 2023 | 72.54 |
| August 01, 2023 | 75.65 |
| July 31, 2023 | 77.59 |
| July 28, 2023 | 73.98 |
| July 27, 2023 | 72.30 |
| July 26, 2023 | 76.47 |
| July 25, 2023 | 74.27 |
| July 24, 2023 | 74.73 |
| July 21, 2023 | 75.45 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.124
Minimum
Jun 10 2019
230.66
Maximum
Feb 27 2023
25.79
Average
8.174
Median
May 05 2021
Price to Book Value Benchmarks
| AbbVie Inc | 35.94 |
| Eli Lilly and Co | 59.59 |
| Aquestive Therapeutics Inc | -- |
| Humacyte Inc | 32.10 |
| AN2 Therapeutics Inc | 0.5840 |
Price to Book Value Related Metrics
| PS Ratio | 1.108 |
| Price | 3.005 |
| Earnings Yield | -121.1% |
| Market Cap | 313.87M |